A clinical trial investigating the safety and biological activity of the antibody BNT351 in adults living without and with HIV
BNT351-01
Phase 1 other active
Quick answer
A clinical trial investigating the safety and biological activity of the antibody BNT351 in adults living without and with HIV for HIV-1 infection is a Phase 1 program (other) at BioNTech Manufacturing GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BioNTech Manufacturing GmbH
- Indication
- HIV-1 infection
- Phase
- Phase 1
- Modality
- other
- Status
- active